STAT

With masks dwindling, a hospital’s Covid-19 crisis team searches for a way out

With the coronavirus bearing down and employees insisting on better protection, a hospital's leaders ask: Where can we get more masks?

This is one in a series of reports from hospitals responding to the Covid-19 pandemic.

“I just want to say … yesterday was a really hard day,” said Chuck Morris, one of the two people now in charge of Brigham and Women’s Hospital. “Personally speaking, I sort of went home in a tough place. We’re finding some rhythm, and then some bombs went off.”

The room he was addressing had dealt with true explosions before. This was the place where the hospital’s incident command had convened seven years ago, in the aftermath of the Boston Marathon bombing: the war room of a military-style hierarchy that, for the length of an emergency, replaces the executives who normally run the show. This time, the bombs weren’t literal. They were cases of Covid-19 that had popped up in parts of the hospital where no one was expecting them: On Thursday, March 19, two patients had come in for other reasons — abdominal surgery for one, a bleeding episode for the other — only for their coronavirus infections to come to light after they’d bounced from unit to unit, potentially exposing over 100 workers.

“Today is another day,” Morris went on, around 8 on Friday morning. “I’m not going to be hokey about it, but I want everyone to close your eyes, and we’re just going to take three deep breaths as a group, and then get ready to just face the day. Just quietly, everybody, please — ”

But then the door swung open, and in walked , the incident command’s section chief for planning, one of the straightest talkers in a room full of straight talkers. “We’re taking deep breaths, Shel,” someone whispered. You didn’t even have to look at Anderson’s face to feel her

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About MDMA For PTSD, A CRISPR Treatment For Blindness, And More
An FDA advisory panel will deliberate on June 4 whether to recommend approval for the first MDMA-assisted therapy for post-traumatic stress disorder.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.

Related Books & Audiobooks